Literature DB >> 7415751

Early recurrence in oestrogen receptor negative breast carcinomas. A preliminary report.

F Hartveit, H Maartmann-Moe, K F Støa, M Tangen, T Thorsen.   

Abstract

The prognostic value of oestrogen receptor analysis is demonstrated in 150 patients with infiltrating breast carcinoma. Recurrence of tumour was earlier and more frequent in the receptor negative than in the receptor positive cases. There was more early deaths in the receptor negative group. The mean follow-up time was 30 months.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7415751

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  6 in total

1.  Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique.

Authors:  S von Kleist; J Berling; J Koltzenburg; H Gropp
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

2.  Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.

Authors:  J M Raemaekers; L V Beex; A J Koenders; G F Pieters; A G Smals; T J Benraad; P W Kloppenborg
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.

Authors:  E Heinonen; A Alanko; P Gröhn; P Rissanen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 4.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

5.  Steroid hormone receptors and prognosis in breast cancer.

Authors:  G Daxenbichler; E P Forsthuber; C Marth; G Kemmler; J Wiegele; R Margreiter; L Müller; H Hausmaninger; D Manfreda; O Dapunt
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

6.  Histological grade and efferent vascular invasion in human breast carcinoma.

Authors:  F Hartveit; S Thoresen; T Thorsen; M Tangen
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.